期刊文献+

3-羟基异戊酰基肉碱代谢异常新生儿遗传学分析 被引量:7

Genetic analysis of newborns with abnormal metabolism of 3-hydroxyisovalerylcarnitine
下载PDF
导出
摘要 目的:探讨新生儿3-羟基异戊酰基肉碱(C5-OH)代谢异常的遗传学原因。方法:收集2018年1月至12月在浙江省新生儿遗传代谢病筛查中心经串联质谱法筛查结果为C5-OH增高的52例新生儿的资料,包括新生儿筛查与复查随访的C5-OH、C5-OH/C3、C5-OH/C8检测数据,并换算成C5-OH增高倍数。采用液相捕获技术靶向捕获MCCC1、MCCC2等79个遗传代谢病相关基因,通过高通量测序和生物信息学分析获取基因的突变信息,参考美国医学遗传学与基因组学学会(ACMG)分类标准进行分级。依据基因检测情况,将C5-OH增高新生儿分为未检出突变组、MCCC1母源突变组、MCCC1父源突变组、MCCC2突变组,采用威尔科克森秩和检验分析不同组间C5-OH增高倍数的差异。结果:37例检出MCCC1突变,涉及21种突变型,其中14种为新发现的突变型;4例检出MCCC2突变,涉及6种突变型,其中5种为新发现的突变型。MCCC1母源突变组、MCCC2突变组的C5-OH增高倍数均高于未检出突变组(均P<0.05),MCCC1父源突变组的C5-OH增高倍数与未检出突变组差异无统计学意义(P>0.05)。结论:MCCC1、MCCC2基因突变是导致新生儿血C5-OH增高的主要遗传学原因,其中母源性单杂合突变可导致中重度C5-OH增高。 Objective: To investigate the genetic characterization of 3-hydroxyisovalerylcarnitine (C5-OH) metabolic abnormality in neonates. Methods: Fifty two newborns with increased C5-OH, C5-OH/C3 and C5-OH/C8 detected by tandem mass spectrometry during neonatal screening were enrolled in the study. Genomic DNA was extracted from the whole blood samples of 52 cases and their parents. Seventy-nine genes associated with genetic and metabolic diseases including MCCC1 , MCCC2 were targeted by liquid capture technique. Variation information of these genes was examined by high-throughput sequencing and bioinformatic analysis, and then was classified based on the American College of Medical Genetics and Genomics (ACMG) standards and guidelines. The genetic types were classified as wild-type, MCCC1 -maternal-mutation, MCCC1 -paternal-mutation and MCCC2 -mutation. Wilcoxon rank-sum test was performed for the increased multiples of C5-OH calculated in neonatal screening. Results: Twenty one MCCC1 variants (14 novel) were identified in 37 cases, 6 MCCC2 variants (5 novel) in 4 cases. The increased multiple of C5-OH calculated in MCCC1 -maternal-mutation and MCCC2 -mutation groups were significantly higher than that in wild-type group (all P <0.05), while there was no significant difference between MCCC1-paternal-mutation group and wild-type group ( P >0.05). Conclusion: Mutations on MCCC1 and MCCC2 genes are the major genetic causes for the increased C5-OH in neonates, and maternal single heterozygous mutation can contribute to the moderately to severely increased C5-OH.
作者 吴鼎文 芦斌 杨建滨 杨茹莱 黄新文 童凡 郑静 赵正言 WU Dingwen;LU Bin;YANG Jianbin;YANG Rulai;HUANG Xinwen;TONG Fan;ZHENG Jing;ZHAO Zhengyan(Zhejiang Neonatal Screening Center, Department of Genetics and Metabolism, the Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China;Zhejiang Biosan Biochemical Technologies Co. Ltd, Hangzhou 310012, China)
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2019年第4期390-396,共7页 Journal of Zhejiang University(Medical Sciences)
基金 浙江省分析测试科技计划(2018C3706) 国家重点研发计划(2018YFC1002700) 浙江省医药卫生科技计划(2015KYA118)
关键词 代谢缺陷 先天性/血液 有机酸类/血液 酰基辅酶A/缺乏 基因/遗传学 质谱分析法 新生儿筛查 Metabolism, inborn errors/blood Organic acids/blood Acyl coenzyme A/deficiency Genes/genetics Mass spectrometry Neonatal screening
  • 相关文献

参考文献1

二级参考文献17

  • 1Millington DS, Kodo N, Norwood DL, et al. Tandem mass spectrometry: a new method for acylcamitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis, 1990,13:321-324.
  • 2Scriver CR, Beaudet AL, Sly WS, et al. The Metabolic and Molecular Bases of Inherited Disease. 8th ed, New-York: McGraw-Hill, 2001 : 1667-2239.
  • 3中华人民共和国卫生部.新生儿疾病筛查技术规范(2010年版).http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohfybjysqwss/s3585/201012/50065.htm,[2010-12-01].
  • 4Wilcken B, Wiley V, Sim KG, et al. Camitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J Pediatr, 2001,138:581-584.
  • 5Niu DM, Chien YH, Chiang CC, et at. Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan. J Inherit Metab Dis, 2010, 33 Supp! 2:295-305.
  • 6Schulze A, Lindner M, Kohlmuller D, et al. Expanded newborn screening for inborn errors of metabolism by electrospray ionization- tandem mass spectrometry: results, outcome, and implications. Pediatrics ,2003,111 : 1399-1406.
  • 7Schulze A, Mayatepek E, Hoffmann GF. Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria. Clin Chim Acta, 2002,317 : 27-37.
  • 8Chace DH, DiPema JC, Mitchell BL, et al. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem, 2001,47 : 1166-1182.
  • 9Turgeon C, Magera MJ, Allard P, et al. Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots. Clin Chem, 2008,54:657-664.
  • 10Naughten ER, Yap S, Mayne PD. Newborn screening for homocystinuria: Irish and world experience. Eur J Pediatr, 1998, 157 Suppl 2:84-87.

共引文献90

同被引文献41

引证文献7

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部